Table 2.
ID | Age range | Living situation | Education levela | Smoking | GOLD stageb | Exacerbations/ yearc |
Mobile technology use |
---|---|---|---|---|---|---|---|
P01 | 50–59 | With life partner | High | Former | 2/3d | 3 | Smartphone & tablet |
P02 | 50–59 | With life partner | Low | Former | 2 | 5 | Smartphone & tablet |
P03 | 50–59 | – | – | – | 2/3 | – | Smartphone & tablet |
P04 | 60–69 | With life partner | Low | Former | 4 | 3 | Tablet |
P05 | 60–69 | Alone | High | Current | 4 | < 1 | Smartphone & tablet |
P06 | 60–69 | With life partner | High | Former | 3 | > 3 | None |
P07 | 70–79 | Alone | High | Former | 2 | 2 | Tablet |
P08 | 80–89 | With life partner | Medium | Former | 2 | 3 | None |
P09 | 50–59 | With life partner | Medium | Former | 4 | 3 | Smartphone & tablet |
P10 | 60–69 | With children | High | Former | 3 | 1 | Smartphone & tablet |
P11 | 60–69 | With life partner | High | Former | 4 | > 3 | Tablet |
P12 | 40–49 | With life partner | Medium | Former | 3 | 3 | Tablet |
P13 | 70–79 | With life partner | Low | Former | 2 | – | None |
Abbreviation: GOLD, Global Initiative for Chronic Obstructive Lung Disease
aLow = primary school through vocational training, medium = secondary school or vocational training, high = college or university degree
baccording to GOLD classification in medical chart;
camount of exacerbations determined by amount of prescriptions of corticosteriods and/or antibiotics for worsening of lung symptoms, estimated by patients themselves;
dpatient self-reported GOLD stage; − = missing data